Clinical Trials Logo

Clinical Trial Summary

Aim of the study:

To investigate if there is a differences in expression of inflammatory markers in venous wall and blood among patients treated with Detralex and those not treated with Detralex (control group).


Clinical Trial Description

Chronic venous disease (CVD) represents one of the most common vascular disorder. It's different clinical manifestations (most often seen as varicose veins) can be observed in up to 40% of adult female population and in about 30% of adult males.

Different mechanical and biological factors play role in the process of deterioration of venous wall tone and consequent vein valve disfunction that eventually lead to increase venous pressure . Evidence suggest that inflammation has a central place in this process even from the early stage of CVD.

Usual symptoms of venous insufficiency are pain, leg heaviness, night cramping, itching, and are often accompanied with leg edema. The extent of clinical manifestation may not correlate with patients' symptoms. Treatment of varicose veins encompasses vein surgery (stripping, phlebectomy, radiofrequency and laser ablation), sclerotherapy and compression therapy. Detralex (in some countries registered as Daflon) is an oral flavonoid that consists of 90% micronized diosmin and 10% flavonoids expressed as hesperidin. Several studies showed some beneficial effects of Detralex in alleviating symptoms in patients with CVD. It may be used in conjunction with surgery, sclerotherapy, or compression therapy or it may be the only therapy when other therapeutical modalities are not indicated or not feasable.

Animal studies showed antiinflammatory effects of Daflon in way that Daflon acts favorably on microcirculatory complications by normalizing the synthesis of prostaglandins and free radicals. It decreases bradykinin-induced microvascular leakage and inhibits leukocyte activation, trapping, and migration.

However, by searching the available literature (MEDLINE) we found no study that investigated what are the antiinflammatory effects of flavonoids in humans.

The aim of this study is to investigate if there is a differences in expression of inflammatory markers in venous wall and blood between patients treated with Detralex and those not treated with Detralex (control group). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01654016
Study type Interventional
Source University Hospital Dubrava
Contact
Status Completed
Phase Phase 4
Start date August 2012
Completion date September 2019

See also
  Status Clinical Trial Phase
Terminated NCT02462096 - A Feasibility Study of the ReLeaf Catheter System N/A
Enrolling by invitation NCT05504070 - Venclose digiRF System Post Market Study N/A
Completed NCT05507346 - A Clinical Study to Evaluate the Effectiveness of a Novel Portable Non-Pneumatic Active Compression Device vs. an Advanced Pneumatic Compression Device for Treating Lower Extremity Lymphedema N/A
Recruiting NCT05622500 - Best Endovenous Treatment, Including STenting, Versus Non-endovenous Treatment in Chronic Proximal Deep Venous Disease N/A
Completed NCT03283800 - Copper Impact on Venous Insufficiency and Lipodermatosclerosis N/A
Terminated NCT02248740 - Radiofrequency Ablation vs. Laser Ablation of the Incompetent Small Saphenous Vein Phase 4
Completed NCT01501188 - Efficacy Study of Kinesio Taping to Treat Muscular and Joint Problems in Chronic Venous Insufficiency Phase 1
Completed NCT02236338 - Radiofrequency Ablation vs Laser Ablation of the Incompetent Greater Saphenous Vein Phase 4
Recruiting NCT05982405 - Long-term Effects of Inspiratory Muscle Training in Chronic Venous Insufficiency N/A
Completed NCT05383469 - Efficacy of Active Versus Passive Methods in Chronic Venous Insufficiency N/A
Completed NCT06238791 - Plantar Pressure Analysis and Foot Biomechanics in Lipedema and Chronic Venous Disease
Withdrawn NCT02559427 - SPA Therapy in the Treatment of Sleep Apnea Syndrome N/A
Completed NCT02346058 - Efficacy and Safety of Esarin Gel in Chronic Venous Insufficiency and Varicose Veins Phase 4
Active, not recruiting NCT05926830 - Extracorporeal Flow Abolition in Relation With Primary Insufficiency of Great Saphenous Veins (GSV) Using High Intensity Focused Ultrasound (HIFU) Generated by Sonovein: A Multi Center Prospective Pivotal Study N/A
Withdrawn NCT05047302 - Investigation of Femoropopliteal In Situ Valve Formation With the InterVene System-Canada N/A
Active, not recruiting NCT04339075 - Registry to Investigate the Efficacy and Safety of VenaBlock VeIn SEaling System for VaRicose Veins in SingApore
Active, not recruiting NCT04580160 - Venous Stent for the Iliofemoral Vein Investigational Clinical Trial Using the DUO Venous Stent System N/A
Not yet recruiting NCT02927483 - Study to Assess the Efficacy and Safety of Endolex Forte VErsus Diosmin and Hesperidin in Reducing VeNous Insufficiency Phase 3
Completed NCT02015221 - Evaluation of a Dual Action Pneumatic Compression Device: Patient Ease of Use and Comfort N/A
Completed NCT02050061 - Chronic Venous Insufficiency; Impact of Compression Stockings on Quality of Life N/A